Periprocedural myocardial injury during elective percutaneous coronary intervention: is it important and how can it be prevented?

被引：63

作者：

Cuculi, F. ^{[1
]}

Lim, C. C. S. ^{[1
]}

Banning, A. P. ^{[1
]}

机构：

[1] Oxford Radcliffe Hosp, Dept Cardiol, Oxford, England

来源：

HEART | 2010年 / 96卷 / 10期

关键词：

CREATINE-KINASE-MB; INTRACORONARY BETA-BLOCKER; STATIN THERAPY; UNFRACTIONATED HEPARIN; UNIVERSAL DEFINITION; RANDOMIZED-TRIAL; CLINICAL-TRIAL; TROPONIN-T; CLOPIDOGREL PRETREATMENT; ANTIPLATELET THERAPY;

D O I：

10.1136/hrt.2009.186189

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Periprocedural myocardial injury (PMI) is common after percutaneous coronary intervention (PCI). Periprocedural infarction (myocardial infarction type 4a) occurs after at least 10% of PCI procedures and has an impact on long-term prognosis. Measurement of biomarkers to allow assessment of PMI is an important tool for clinical and research purposes and should be routine after every PCI (troponin I or T and CK-MB). The importance of oral and intravenous antiplatelet agents and other drugs which have been proven to reduce PMI is discussed.

引用

页码：736 / 740

页数：5

共 66 条

[61] Effect of Two-Day Atorvastatin Pretreatment on the Incidence of Periprocedural Myocardial Infarction Following Elective Percutaneous Coronary Intervention: A Single-Center, Prospective, and Randomized Study
Veselka, Josef
Zemanek, David
Hajek, Petr
Maly, Martin
Adlova, Radka
Martinkovicova, Lucie
Tesar, David
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (05) : 630 - 633
[62] Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Wallentin, Lars
Becker, Richard C.
Budaj, Andrzej
Cannon, Christopher P.
Emanuelsson, Hakan
Held, Claes
Horrow, Jay
Husted, Steen
James, Stefan
Katus, Hugo
Mahaffey, Kenneth W.
Scirica, Benjamin M.
Skene, Allan
Steg, Philippe Gabriel
Storey, Robert F.
Harrington, Robert A.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (11) : 1045 - 1057
[63] Distal myocardial protection during percutaneous coronary intervention with an intracoronary β-blocker
Wang, FW
Osman, A
Otero, J
Stouffer, GA
Waxman, S
Afzal, A
Anzuini, A
Uretsky, BF
[J]. CIRCULATION, 2003, 107 (23) : 2914 - 2919
[64] Clopidogrel pre-treatment in stable angina:: for all patients >6 h before elective coronary angiography or only for angiographically selected patients a few minutes before PCI?: A randomized multicentre trial PRAGUE-8
Widimsky, Petr
Motovska, Zuzana
Simek, Stanislav
Kala, Petr
Pudil, Radek
Holm, Frantisek
Petr, Robert
Bilkova, Dana
Skalicka, Hana
Kuchynka, Petr
Poloczek, Martin
Miklik, Roman
Maly, Marek
Aschermann, Michael
[J]. EUROPEAN HEART JOURNAL, 2008, 29 (12) : 1495 - 1503
[65] Prasugrel versus clopidogrel in patients with acute coronary syndromes
Wiviott, Stephen D.
Braunwald, Eugene
McCabe, Carolyn H.
Montalescot, Gilles
Ruzyllo, Witold
Gottlieb, Shmuel
Neumann, Franz-Joseph
Ardissino, Diego
De Servi, Stefano
Murphy, Sabina A.
Riesmeyer, Jeffrey
Weerakkody, Govinda
Gibson, C. Michael
Antman, Elliott M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (20) : 2001 - 2015
[66] 1997, LANCET, V349, P1422

← 1 2 3 4 5 6 7 →